Search

Filters

Use filters to refine the search results.

Current Filters:



New Filters:

Showing 50 out of a total of 226 results. (0.046 seconds)

Now showing items 1-50 of 226

1
2
3
4
. . .
5
Next Page

Export Results

Sort Options:
Results Per Page:
- 50
- 100
- 150
- 200

Long-term efficacy of low-dose radiation therapy on symptoms in patients with knee and hand osteoarthritis: follow-up results of two parallel randomised, sham-controlled trials

Ende, C.H.M. van den ; Minten, M.J.M.; Leseman-Hoogenboom, M.M.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Mahler, E.A.; Poortmans, P.M.P.

2020, Article / Letter to editor (The Lancet. Rheumatology, vol. 2, iss. 1, (2020), pp. E42-E49)
Room for improvement in non-pharmacological systemic sclerosis care? - a cross-sectional online survey of 650 patients

Stocker, J.K.; Vonk, M.C. ; Hoogen, F.H.J. van den ; Nijhuis-van der Sanden, M.W.G. ; Spierings, J.; Staal, J.B. ; Satink, T.J.; Ende, C.H.M. van den

2020, Article / Letter to editor (BMC Rheumatology, vol. 4, (2020), article 43)
Response To: 'Effectiveness of Low-Dose Radiation Therapy on Symptoms in Patients With Knee Osteoarthritis'

Mahler, E.A.; Minten, M.J.M.; Leseman-Hoogenboom, M.M.; Poortmans, P.M.P.; Leer, J.W.H. ; Boks, S.S.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Ende, C.H.M. van den

2020, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 79, iss. 2, (2020), pp. 1-2, article e25)
TGF beta-mediated expression of TGF beta-activating integrins in SSc monocytes: disturbed activation of latent TGF beta?

Caam, A.P. van; Aarts, J. ; Ee, T.J. van ; Vitters, E.L. ; Koenders, M.I. ; Loo, F. van de ; Lent, P.L. van ; Hoogen, F.H.J. van den ; Thurlings, R.M.; Vonk, M.C. ; Kraan, P.M. van der et al. sine al.

2020, Article / Letter to editor (Arthritis Research & Therapy, vol. 22, iss. 1, (2020), article 42)
Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial

Michielsens, C.A.J. ; Boers, N.; Broeder, N. den ; Wenink, M.H. ; Maas, A. van der; Mahler, E.A.; Mulder, M.L.M.; Hoogen, F.H.J. van den ; Verhoef, L.M. ; Broeder, A.A. den

2020, Article / Letter to editor (Trials, vol. 21, iss. 1, (2020), article 90)
Exploring healthcare professionals' knowledge, attitudes and experiences of shared decision making in rheumatology

Mathijssen, E.G.E. ; Bemt, B.J.F van den ; Wielsma, S.; Hoogen, F.H.J. van den ; Vriezekolk, J.E.

2020, Article / Letter to editor (Rheumatic & Musculoskeletal Diseases Open, vol. 6, iss. 1, (2020), article e001121)
Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis

Kersten, B.E. ; Broeder, N. den ; Hoogen, F.H.J. van den ; Knaapen, H.K.A. ; Ende, C.H.M. van den ; Vonk, M.C.

2020, Article / Letter to editor (Rheumatology, vol. 59, iss. 7, (2020), pp. 1550-1555)
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)

Mulder, M.L.M.; Vriezekolk, J.E.; Broeder, N. den ; Mahler, E.A.; Helliwell, Philip S.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Wenink, M.H.

2020, Article / Letter to editor (Trials, vol. 21, iss. 1, (2020), article 155)
Effect of the dr. Bart application on healthcare use and clinical outcomes in people with osteoarthritis of the knee and/or hip in the Netherlands; a randomized controlled trial

Pelle, T.; Bevers, Karen; Palen, J. van der; Hoogen, F.H.J. van den ; Ende, C.H.M. van den

2020, Article / Letter to editor (Osteoarthritis and Cartilage, vol. 28, iss. 4, (2020), pp. 418-427)
Response to: 'Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis' by Wu et al

Mahler, E.A.; Minten, M.J.M.; Leseman-Hoogenboom, M.M.; Poortmans, P.M.P.; Leer, J.W.H. ; Boks, S.S.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Ende, C.H.M. van den

2020, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 79, iss. 2, (2020), article e25)
Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero et al

Mahler, E.A.; Minten, M.J.M.; Leseman-Hoogenboom, M.M.; Poortmans, P.M.P.; Leer, J.W.H. ; Boks, S.S.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Ende, C.H.M. van den

2020, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 79, iss. 3, (2020), article e35)
Interventions to support shared decision making for medication therapy in long term conditions: A systematic review

Mathijssen, E.G.E. ; Bemt, B.J.F van den ; Hoogen, F.H.J. van den ; Popa, C. ; Vriezekolk, J.E.

2020, Article / Letter to editor (Patient Education and Counseling, vol. 103, iss. 2, (2020), pp. 254-265)
Comparison of physical activity among different subsets of patients with knee or hip osteoarthritis and the general population

Pelle, T.; Claassen, AAOM; Meessen, Jennifer M.T.A.; Peter, W.F.; Vliet Vlieland, T.P.M.; Bevers, Karen; Hoogen, F.H.J. van den ; Ende, C.H.M. van den

2020, Article / Letter to editor (Rheumatology International, vol. 40, iss. 3, (2020), pp. 383-392)
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study

Bijnen, S.T. van ; Vries-Bouwstra, J.K. de; Ende, C.H.M. van den ; Boonstra, Maaike; Kroft, Lucie; Geurts, B.H.; Snoeren, M.M. ; Velden, W.J. van der ; Hoogen, F.H.J. van den ; Vonk, M.C.

2020, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 79, iss. 8, (2020), pp. 1084-1089)
Preparing for an orthopedic consultation using an eHealth tool: a randomized controlled trial in patients with hip and knee osteoarthritis

Claassen, AAOM; Schers, H.J. ; Busch, V.J.J.F ; Heesterbeek, P.J.C. ; Hoogen, F.H.J. van den ; Vliet Vlieland, T.P.M.; Ende, C.H.M. van den

2020, Article / Letter to editor (BMC Medical Informatics and Decision Making, vol. 20, iss. 1, (2020), article 92)
Short fatigue questionnaire: Screening for severe fatigue.

Penson, A. ; Deuren, S van ; Worm-Smeitink, M.G.M. ; Bronkhorst, E.M. ; Hoogen, F.H.J. van den ; Engelen, B.G.M. van ; Peters, M.E.W.J. ; Bleijenberg, G. ; Vercoulen, J.H. ; Blijlevens, N.M.A. ; Loonen, J.J. ; Knoop, H. et al. sine al.

2020, Article / Letter to editor (Journal of Psychosomatic Research, vol. 137, (2020), article 110229)
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key

Broeder, N. den ; Bouman, C.A.M.; Kievit, W. ; Herwaarden, N. van; Hoogen, F.H.J. van den ; Vollenhoven, R.F. van; Bijlsma, H.W.J.; Maas, A. van der; Broeder, A.A. den

2019, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 78, iss. 1, (2019), pp. 141-142)
Short-term clinical worsening is a clear predictor for worsening at 2 years in established knee and hip osteoarthritis

Mahler, E.A.; Broeder, A.A. den ; Broeder, N. den ; Bijlsma, J.W.; Snijders, G.F.; Hoogen, F.H.J. van den ; Ende, C.H.M. van den

2019, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 37, iss. 3, (2019), pp. 414-421)
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Verhoef, L.M. ; Bemt, B.J.F van den ; Maas, A. van der; Vriezekolk, J.E.; Hulscher, M.E.J.L. ; Hoogen, F.H.J. van den ; Jacobs, W.C.; Herwaarden, N. van; Broeder, A.A. den

2019, Article / Letter to editor (Cochrane Database of Systematic Reviews, vol. 5, (2019), pp. Cd010455)
Most Important Frequently Asked Questions From Patients With Hip or Knee Osteoarthritis: A Best-Worst Scaling Exercise

Claassen, A.; Hei, K. Kremers-van de; Hoogen, F.H.J. van den ; Laan, W.H. van der; Rijnen, W.H.C. ; Koeter, S. ; Botman, J.; Busch, V.; Schers, H.J. ; Ende, C.H.M. van den

2019, Article / Letter to editor (Arthritis Care & Research, vol. 71, iss. 7, (2019), pp. 885-892)
Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial

Mahler, E.A.; Minten, M.J.M.; Leseman-Hoogenboom, M.M.; Poortmans, P.M.P.; Leer, J.W.H. ; Boks, Simone S.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Ende, C.H.M. van den

2019, Article / Letter to editor (Annals of the Rheumatic Diseases, vol. 78, iss. 1, (2019), pp. 83-90)
Exploring longitudinal associations of histologically assessed inflammation with symptoms and radiographic damage in knee osteoarthritis: combined results of three prospective cohort studies

Minten, M.J.M.; Blom, A.B. ; Snijders, G.F.; Kloppenburg, M.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Kraan, P.M. van der ; Ende, C.H.M. van den

2019, Article / Letter to editor (Osteoarthritis and Cartilage, vol. 27, iss. 1, (2019), pp. 71-79)
An Electronic Health Tool to Prepare for the First Orthopedic Consultation: Use and Usability Study

Claassen, AAOM; Vliet Vlieland, T.P.M.; Busch, V.J.J.F ; Schers, H.J. ; Hoogen, F.H.J. van den ; Ende, C.H.M. van den

2019, Article / Letter to editor (JMIR Formative Research, vol. 3, iss. 4, (2019), pp. e13577)
Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study

Verhoef, L.M. ; Bos, D.; Ende, C.H.M. van den ; Hoogen, F.H.J. van den ; Fautrel, B.; Hulscher, M.E.J.L. ; Kievit, W. ; Broeder, A.A. den

2019, Article / Letter to editor (Scandinavian Journal of Rheumatology, vol. 48, iss. 6, (2019), pp. 439-447)
Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?

Mulder, M.L.M.; Broeder, A.A. den ; Ginneken, B.T.J. van; Mahler, E.A.; Hoogen, F.H.J. van den ; Vriezekolk, J.E.; Wenink, M.H.

2019, Article / Letter to editor (Rheumatology, vol. 58, iss. 12, (2019), pp. 2330-2331)
Development and evaluation of a tailored e-self-management intervention (dr. Bart app) for knee and/or hip osteoarthritis: study protocol

Pelle, Tim; Bevers, Karen; Palen, J.A.M. van der; Hoogen, F.H.J. van den ; Ende, C.H.M. van den

2019, Article / Letter to editor (BMC Musculoskeletal Disorders, vol. 20, iss. 1, (2019), article 398)
Predictive value of ex-vivo drug-inhibited cytokine production for clinical response to biologic DMARD therapy in rheumatoid arthritis

Tweehuysen, L.; Broeder, A.A. den ; Schraa, K. ; Netea, M.G. ; Hoogen, F.H.J. van den ; Joosten, L.A.B.

2019, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 37, iss. 3, (2019), pp. 367-372)
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent

Kristensen, L.E.; Alten, R.; Puig, L.; Philipp, S.; Kvien, T.K.; Mangues, Maria Antonia; Hoogen, F.H.J. van den ; Pavelka, K.; Vulto, A.G.

2018, Article / Letter to editor (Biodrugs, vol. 32, iss. 5, (2018), pp. 397-404)
Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Hombergh, W.M.T. van den; Simons, S.; Teesselink, E.; Knaapen-Hans, H.K.A. ; Hoogen, F.H.J. van den ; Fransen, J. ; Vonk, M.C.

2018, Article / Letter to editor (Clinical Rheumatology, vol. 37, iss. 10, (2018), pp. 2715-2722)
The Scleroderma Patient-Centered Intervention Network Cohort: Baseline clinical features and comparison with other large scleroderma cohorts

Dougherty, D.H.; Kwakkenbos, L. ; Carrier, M.E.; Salazar, G.A.; Assassi, S.; Baron, M.; Bartlett, S.J.; Furst, D.E.; Gottesman, K.; Hoogen, F.H.J. van den ; Malcarne, V.L.; Mouthon, L.; Nielson, W.R.; Poiraudeau, S.; Sauvé, M.; Boire, G.; Bruns, A.; Chung, L.; Denton, C.P.; Dunne, J.V.; Fortin, P.R.; Frech, T.; Gill, A.; Gordon, J.K.; Herrick, A.L.; Hinchcliff, M.; Hudson, M.; Johnson, S.R.; Jones, N.; Kafaja, S.; Larché, M.; Manning, J.B.; Pope, J.; Spiera, R.F.; Steen, V.; Sutton, E.; Thorne, J.C.; Wilcox, P.G.; Thombs, B.D.; Mayes, M.D. et al. sine al.

2018, Article / Letter to editor (Rheumatology, vol. 57, iss. 9, (2018), pp. 1623-1631)
Treatment Beliefs Underlying Intended Treatment Choices in Knee and Hip Osteoarthritis

Selten, E.M.H.; Geenen, R.; Schers, H.J. ; Hoogen, F.H.J. van den ; Meulen-Dilling, R.G. van der; Laan, W.H. van der; Ende, C.H.M. van den ; Vriezekolk, J.E.

2018, Article / Letter to editor (International Journal of Behavioral Medicine, vol. 25, iss. 2, (2018), pp. 198-206)
What moves the rheumatologist? Unravelling decision making in the referral of systemic sclerosis patients to health professionals: a qualitative study

Stocker, J.K.; Cup, E.H.C. ; Vonk, M.C. ; Hoogen, F.H.J. van den ; Nijhuis-van der Sanden, M.W.G. ; Staal, J.B. ; Ende, C.H.M. van den

2018, Article / Letter to editor (Rheumatology Advances in Practice, vol. 2, iss. 2, (2018), pp. rky027)
Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity

Arntz, O.J. ; Pieters, B.C.H. ; Thurlings, R.M.; Wenink, Mark H.; Lent, P.L.E.M. van ; Koenders, M.I. ; Hoogen, F.H.J. van den ; Kraan, P.M. van der ; Loo, F.A.J. van de

2018, Article / Letter to editor (Frontiers in Immunology, vol. 9, (2018), article 2388)
Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial

Hombergh, W.M.T. van den; Kersten, B.E. ; Knaapen-Hans, H.K.A. ; Thurlings, R.M.; Kraan, P.M. van der ; Hoogen, F.H.J. van den ; Fransen, J. ; Vonk, M.C.

2018, Article / Letter to editor (Trials, vol. 19, (2018), article 449)
Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis

Tweehuysen, L; Broeder, N. den; Herwaarden, N. van; Joosten, L.A.B. ; Lent, P.L. van ; Vogl, T.; Hoogen, F.H.J. van den ; Thurlings, R.M.; Broeder, A.A. den

2018, Article / Letter to editor (Rheumatic & Musculoskeletal Diseases Open, vol. 4, iss. 1, (2018), article e000654)
Unraveling SSc Pathophysiology; The Myofibroblast

Caam, A.P. van; Vonk, M.C. ; Hoogen, F.H.J. van den ; Lent, P.L. van ; Kraan, P.M. van der

2018, Article / Letter to editor (Frontiers in Immunology, vol. 9, (2018), article 2452)
Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4 Six-Month Results From a Controlled Cohort Study

Tweehuysen, L; Huiskes, V.J.B. ; Bemt, B.J.F van den ; Vriezekolk, J.E.; Teerenstra, S. ; Hoogen, F.H.J. van den ; Ende, C.H.M. van den ; Broeder, A.A. den

2018, Article / Letter to editor (Arthritis & Rheumatology, vol. 70, iss. 9, (2018), pp. 1408-1418)
Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial

Minten, M.J.M.; Leseman-Hoogenboom, M.M.; Kloppenburg, M.; Kortekaas, M.C.; Leer, J.W.H. ; Poortmans, P.M.P.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Ende, C.H.M. van den

2018, Article / Letter to editor (Osteoarthritis and Cartilage, vol. 26, iss. 10, (2018), pp. 1283-1290)
Patient Acceptable Symptom State in Knee Osteoarthritis Patients Succeeds Across Different Patient-reported Outcome Measures Assessing Physical Function, But Fails Across Other Dimensions and Rheumatic Diseases

Mahler, E.A.; Boers, N.; Bijlsma, Johannes W. J.; Hoogen, F.H.J. van den ; Broeder, A.A. den ; Ende, C.H.M. van den

2018, Article / Letter to editor (The Journal of Rheumatology, vol. 45, iss. 1, (2018), pp. 122-127)
Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis

Mathijssen, E.G.E. ; Vriezekolk, J.E.; Eijsbouts, A.M.M.; Hoogen, F.H.J. van den ; Bemt, B.J.F van den

2018, Article / Letter to editor (Patient Preference and Adherence, vol. 12, (2018), pp. 349-358)
Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab

Tweehuysen, L; Bemt, B.J.F van den ; Ingen, I.L. van; Jong, Alphons J. L. de; Laan, W.H. van der; Hoogen, F.H.J. van den ; Broeder, A.A. den

2018, Article / Letter to editor (Arthritis & Rheumatology, vol. 70, iss. 1, (2018), pp. 60-68)
There is a need for new systemic sclerosis subset criteria. A content analytic approach

Johnson, S.R.; Soowamber, M.L.; Fransen, J. ; Khanna, D.; Hoogen, F.H.J. van den ; Baron, M.; Matucci-Cerinic, M.; Denton, C.P.; Medsger, T.A.; Carreira, P.E.; Riemekasten, G.; Distler, J.; Gabrielli, A.; Steen, V.; Chung, L.; Silver, R.; Varga, J.; Muller-Ladner, U.; Vonk, M.C. ; Walker, U.A.; Wollheim, F.A.; Herrick, A.; Furst, D.E.; Czirjak, L.; Kowal-Bielecka, O.; Galdo, F. Del; Cutolo, M.; Hunzelmann, N.; Murray, C.D.; Foeldvari, I.; Mouthon, L.; Damjanov, N.; Kahaleh, B.; Frech, T.; Assassi, S.; Saketkoo, L.A.; Pope, J.E. et al. sine al.

2018, Article / Letter to editor (Scandinavian Journal of Rheumatology, vol. 2018, iss. 1, (2018), pp. 62-70)
The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study

Verhoef, Lise M. ; Selten, Ellen M.H.; Vriezekolk, J.E.; Jong, Alphons J. L. de; Hoogen, F.H.J. van den ; Broeder, A.A. den; Hulscher, M. ; Broeder, A.A. den

2018, Article / Letter to editor (Rheumatology, vol. 57, iss. 11, (2018), pp. 1947-1955)
Ex vivo inhibited cytokine profiling may explain inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis

Tweehuysen, L; Schraa, K. ; Netea, M.G. ; Hoogen, F.H.J. van den ; Joosten, L.A.B. ; Broeder, A.A. den

2018, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 36, iss. 1, (2018), pp. 140-143)
Milk-Derived Nanoparticle Fraction Promotes the Formation of Small Osteoclasts But Reduces Bone Resorption

Oliveira, M.C.; Di Ceglie, I.; Arntz, O.J. ; Berg, W.B. van den ; Hoogen, F.H.J. van den ; Ferreira, A.V.; Lent, P.L.E.M. van ; Loo, F.A.J. van de

2017, Article / Letter to editor (Journal of Cellular Physiology, vol. 232, iss. 1, (2017), pp. 225-233)
Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement

Bouman, C.; Herwaarden, N. van; Hoogen, F.H.J. van den ; Maas, A. van der; Bemt, B.J.F van den ; Broeder, A. den

2017, Article / Letter to editor (Expert Opinion on Drug Metabolism & Toxicology, vol. 13, iss. 6, (2017), pp. 597-604)
What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

Bouman, C.A.M.; Broeder, A.A. den ; Maas, A. van der; Hoogen, F.H.J. van den ; Landewe, R.B.; Herwaarden, N. van

2017, Article / Letter to editor (Rheumatic & Musculoskeletal Diseases Open, vol. 3, iss. 1, (2017), pp. e000327)
A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes

Bouman, C.A.M.; Maas, A. van der; Herwaarden, N. van; Sasso, E.H.; Hoogen, F.H.J. van den ; Broeder, A. den

2017, Article / Letter to editor (Rheumatology, vol. 56, iss. 6, (2017), pp. 973-980)
Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial

Broeder, A. den; Verhoef, L.M. ; Fransen, J. ; Thurlings, R.M.; Bemt, B.J.F van den ; Teerenstra, S. ; Boers, N.; Broeder, N. den; Hoogen, F.H.J. van den

2017, Article / Letter to editor (Trials, vol. 18, (2017), article 403)
Three-year trajectories of disability and fatigue in systemic sclerosis: A cohort study

Willems, L.M.; Kwakkenbos, L. ; Vonk, M.C. ; Hoogen, F.H.J. van den ; Vliet Vlieland, T.P.M.; Ende, C.H.M. van den

2017, Article / Letter to editor (Clinical and Experimental Rheumatology, vol. 35, iss. 4, Suppl. 106, (2017), pp. 48-55)

Now showing items 1-50 of 226

1
2
3
4
. . .
5
Next Page

Radboud Repository

Search

Showing 50 out of a total of 226 results. (0.046 seconds)

Explore

Author

Document type

Date Issued

Journal

Departments

Browse

All of Repository